Ramy Farid
President & CEO at Schrodinger Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Schrodinger Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Schrodinger Inc. June 18, 202481.4%
-
Vir Biotechnology Inc. May 29, 202499.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| Apr 17, 2026 | Schrodinger Inc. | Option exercise | +43,000 | $3.07 | $132,010 |
| Apr 17, 2026 | Schrodinger Inc. | Open-market sale | −43,000 | $12.21 | $525,030 |
| Apr 17, 2026 | Schrodinger Inc. | Option exercise | +74,527 | $3.07 | $228,798 |
| Apr 16, 2026 | Schrodinger Inc. | Option exercise | +43,000 | $3.07 | $132,010 |
| Apr 16, 2026 | Schrodinger Inc. | Open-market sale | −43,000 | $12.33 | $530,190 |
| Mar 5, 2026 | Schrodinger Inc. | Open-market sale | −3,661 | $12.91 | $47,264 |
| Mar 2, 2026 | Schrodinger Inc. | Grant or award | +56,250 | — | — |
| Mar 2, 2026 | Schrodinger Inc. | Grant or award | +13,604 | — | — |
| Mar 2, 2026 | Schrodinger Inc. | Grant or award | +48,259 | — | — |
| Mar 2, 2026 | Schrodinger Inc. | Open-market sale | −5,560 | $11.90 | $66,164 |
| May 30, 2025 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| Mar 3, 2025 | Schrodinger Inc. | Grant or award | +37,500 | — | — |
| May 29, 2024 | Vir Biotechnology Inc. | Grant or award | +16,000 | — | — |
| Feb 7, 2023 | Structure Therapeutics Inc. | Derivative conversion | +642,245 | — | — |
Questions about Ramy Farid
What boards is Ramy Farid on?
Ramy Farid sits on the boards of Schrodinger Inc., Structure Therapeutics Inc. and Vir Biotechnology Inc.
What company is Ramy Farid the CEO of?
Ramy Farid is President & CEO of Schrodinger Inc.
How long has Ramy Farid served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.